Examples
|
| Reyataz | atazanavir | |
| Prezista | darunavir | |
| Lexiva | fosamprenavir | |
| Crixivan | indinavir | |
| Kaletra | lopinavir and ritonavir | |
| Viracept | nelfinavir | |
| Norvir | ritonavir | |
| Invirase | saquinavir | |
| Aptivus | tipranavir | |
Some of these medicines must be used with ritonavir. They
are only approved for people who have tried other antiretroviral medicines but
did not improve.
How It Works
Protease inhibitors (PIs) are
antiretroviral medicines. They prevent
HIV from multiplying, reducing the amount of virus in
your body. When the amount of virus in the blood is kept at a minimum, the
immune system has a chance to recover and grow
stronger.
Why It Is Used
The use of three or more
antiretroviral medicines (highly active antiretroviral therapy, or HAART) is the usual treatment for HIV infection.
The
combination of medicines used for HAART will depend on your health, other
conditions you might have (such as
hepatitis), and results of testing. Talk to your
doctor about the best treatment plan for you.
Treatment guidelines
suggest the following for people with HIV:1
- When considering treatment, experts currently consider your CD4+
cell count and the presence or absence of symptoms much more important than
your viral load.
- If your
CD4+ cell count is below 350 cells per microliter
(mcL), you should begin treatment to stabilize and increase your CD4+ cell
count.
- If your CD4+ cell count is more than 350 cells per microliter,
treatment may be offered to help keep your immune system healthy and prevent
AIDS.
- If treatment is not started, your condition will be
monitored with frequent CD4+ cell counts.
- If you have symptoms of
HIV or AIDS, you should consider starting treatment, whatever your CD4+ cell
count is.
- If you are pregnant, you should be treated to prevent your unborn
baby (fetus) from becoming infected with HIV.
- If
you also have
hepatitis B and are starting treatment for it, you
should begin treatment for HIV as well.
Should I start antiretroviral medicines for HIV infection even though I have no symptoms?
HIV: Taking antiretroviral medicines
After HIV has progressed to AIDS, treatment is
recommended.1
How Well It Works
Combination therapy:
- Reduces viral loads, which can lead to stable
or increased CD4+ cell counts, a sign that the immune system is still able to
fight off
opportunistic infections.
- Decreases the
number and severity of opportunistic infections.
- Reduces or
prevents the occurrence of
resistance to the medicines.
- Prolongs life.
Antiretroviral therapy can also decrease symptoms of HIV
infection, such as fever and weakness, and help the person gain weight.
The rate at which antiretrovirals decrease viral loads is affected
by:1
- CD4+ cell counts at the beginning of
treatment.
- Viral load at the beginning of
treatment.
- The dosage of the medicines.
- Whether the
medicines are taken exactly as prescribed.
- Whether antiretroviral
medicines have been taken before.
- Whether any
opportunistic infections are present.
Side Effects
To prevent serious medicine
interactions or a decrease in medicine effectiveness, it is important to learn
which medicine should not be taken with PIs and other antiretroviral
medicines.
PIs may cause:
In addition, each medicine may be associated with its own
unique side effects.
Atazanavir (Reyataz)
Side effects of atazanavir include:
- Increased levels of
bilirubin that can make the skin, nails, and whites of
the eyes appear yellow.
- Abnormal heartbeat.
- Headaches.
- Pain or numbness in the
arms and legs.
- Nausea, diarrhea, abdominal
cramps.
- Rash.
Darunavir (Prezista)
Side effects of darunavir include:
- Diarrhea and
nausea.
- Headaches.
- Rash.
- Liver
problems.
Fosamprenavir (Lexiva)
Side effects of fosamprenavir include:
- Appetite
loss.
- Headache.
- Diarrhea, nausea, and
vomiting.
- Abnormal fat distribution on the body.
Indinavir (Crixivan)
Side effects of indinavir include:
- Kidney stones,
reported in 5% of people who use this medicine. The risk of kidney stones can
be reduced by drinking at least
48 fl oz (1.4 L) of fluid each
day.
- Mild stomach problems.
- Dry skin and lips.
- Loss of body hair.
Lopinavir and ritonavir (Kaletra)
Side effects of lopinavir and ritonavir
include:
- Diarrhea.
- Fatigue.
- Headache.
- Nausea.
- Increased
cholesterol and triglyceride levels, which may require
treatment.
- Pancreatitis
(rare).
Nelfinavir (Viracept)
Nelfinavir's most common side effect is diarrhea, which may be severe.
Diarrhea can usually be controlled with nonprescription medicine such as
loperamide (for example, Imodium AD) or calcium supplements, such as Tums.
Ritonavir (Norvir)
Ritonavir
can cause severe side effects at higher doses. But it is usually used at very
low doses to help other medicines work better. At these low doses, side effects
are much less common. Side effects may include:
- Diarrhea.
- Nausea or
vomiting.
- Loss of
appetite.
- Headache.
- Fatigue or
weakness.
- Tingling around the mouth.
- Changes in the way
foods taste.
Saquinavir (Invirase)
Saquinavir has few side effects, which may include:
- Diarrhea.
- Nausea.
- Abdominal
pain.
- Rash.
Tipranavir (Aptivus)
Side effects of tipranavir include:
- Diarrhea, nausea, and
vomiting.
- Belly pain.
-
Headaches.
- Tiredness.
- Liver problems, especially if you
have liver disease.
Report all side effects to your health professional at your
next visit. He or she can adjust your dose or give you other medicines to
reduce side effects. Some mild side effects, such as nausea, improve as your
body adjusts to the medicine.
See Drug Reference for a full list
of side effects. (Drug Reference is not available in all systems.)
What To Think About
Many people think antiretroviral
medicines always have severe side effects. In fact, only a few people
experience severe or dangerous side effects.
Food increases the
absorption of atazanavir (Reyataz), nelfinavir (Viracept), and darunavir
(Prezista).2 Certain acid-reducing medicines, such as
omeprazole (Prilosec) or famotidine (Pepcid), should not be taken at the same
time as Reyataz. Be sure to tell your doctor about any other medicines you are
taking before taking protease inhibitors.
Resistance to PIs
develops more frequently if these medicines are used alone or are not taken
exactly as prescribed.
Ritonavir has negative interactions with
many other medicines. Provide your health professional with a complete list of
prescription and nonprescription medicines you are taking before you start
taking ritonavir.
Lopinavir is combined with a low dose of
ritonavir to inhibit the breakdown of lopinavir in the body. This delayed
breakdown of lopinavir increases its effectiveness.
Lopinavir and
ritonavir (Kaletra) and most other PIs can cause a rise in cholesterol and
triglyceride levels, increasing the risk of pancreatitis.
PIs are
expensive. They can cost up to 2 times more than nucleoside/nucleotide reverse
transcriptase inhibitors (NNRTIs).
Factors to consider when
choosing a combination of medicines include:
- The ability of the medicines to reduce your
viral load.
- The likelihood the virus will develop resistance to a
certain class of medicine. If you have already been treated with a certain
antiretroviral medicine, you may already know whether you are resistant to
medicines in that class.
- Side effects and your willingness to
tolerate them.
- The cost of treatment.
Do not use the nonprescription herbal supplement
St. John's wort while you are taking a protease inhibitor because St. John's
wort can interfere with the effectiveness of these medicines.
Talk
to your doctor about whether you can eat grapefruit or drink grapefruit juice
while you are taking protease inhibitors. It may increase the side effects of
some of these medicines.3
Complete the new medication information form (PDF)
(What is a PDF document?)
to help you understand this medication.
References
Citations
U.S. Department of Health and Human Services (2007).
Guidelines for the use of antiretroviral agents in HIV-1-infected adults and
adolescents. Adult and Adolescent Guidelines. Available
online:
http://www.aidsinfo.nih.gov/guidelines/GuidelineDetail.aspx?MenuItem=Guidelines&Search=Off&GuidelineID=7&ClassID=1.
Atazanavir (Reyataz) and emtricitabine (Emtriva) for
HIV infection (2003). Medical Letter on Drugs and Therapeutics, 45(1169): 90-92.
Tatro DS (2004, January). Keeping up: Interactions of
herbal supplements and grapefruit juice with medications used to treat HIV
infection. Drug Facts and Comparisons News: 3-5.
Credits
| Author | Maria G. Essig, MS, ELS |
| Editor | Susan Van Houten, RN, BSN, MBA |
| Associate Editor | Tracy Landauer |
| Primary Medical Reviewer | Caroline S. Rhoads, MD - Internal Medicine |
| Specialist Medical Reviewer | Peter Shalit, MD, PhD - Internal Medicine |
| Last Updated | May 8, 2008 |
U.S. Department of Health and Human Services (2007).
Guidelines for the use of antiretroviral agents in HIV-1-infected adults and
adolescents. Adult and Adolescent Guidelines. Available
online:
http://www.aidsinfo.nih.gov/guidelines/GuidelineDetail.aspx?MenuItem=Guidelines&Search=Off&GuidelineID=7&ClassID=1.
Atazanavir (Reyataz) and emtricitabine (Emtriva) for
HIV infection (2003). Medical Letter on Drugs and Therapeutics, 45(1169): 90-92.
Tatro DS (2004, January). Keeping up: Interactions of
herbal supplements and grapefruit juice with medications used to treat HIV
infection. Drug Facts and Comparisons News: 3-5.